Post COVID-19 Condition: Testing, Identification & Diagnosis Related to PCC

Описание: Speakers:
Drs. Emilia Liana Falcone and Reem Mustafa

Title:
Post COVID-19 Condition: Testing, Identification & Diagnosis Related to PCC

Session Learning Objectives:
At the end of this session, participants will be able to: identify the value of testing, identification and diagnosis of Post COVID-19 Condition; describe appropriate steps for testing, identification and diagnosis of Post COVID-19 Condition; and integrate CAN-PCC guidelines for testing, identification and diagnosis of Post COVID-19 Condition into healthcare practice.

Recommendations Covered:

GT2:
3. Should C-reactive protein (CRP) versus no C-reactive protein (CRP) be used in people with suspected post COVID-19 condition?

5. Should tools to assess functional status and quality of life (e.g., Post-covid-19 functional status scale, and EuroQol-5D [EQ-5D]) versus no tools be used in people with suspected post COVID-19 condition who have fatigue or dizzinesss?

6. Should ambulatory oximetry versus no ambulatory oximetry be used in people with suspected post COVID-19 condition who have respiratory or cardiac complaints?

7. Should electrocardiogram (EKG or ECG) versus no an electrocardiogram (EKG or ECG be used in people with suspected post COVID-19 condition who have respiratory or cardiac complaints?

8. Should a chest x-ray versus no chest x-ray be used in people with suspected post COVID-19 condition who have respiratory or cardiac complaints?

9. Should a Holter monitor versus no Holter monitor be used in people with suspected post COVID-19 condition who have respiratory or cardiac complaints?

12. Should B-type natriuretic peptide (BNP)/N-terminal pro b-type natriuretic peptide (NT-proBNP) versus no BNP/NT-proBNP be used in adults with suspected post COVID-19 condition who have respiratory or cardiac complaints?

13. Should Troponin (High sensitive Troponin I) versus no Troponin (High sensitive Troponin I) be used in adults with suspected post COVID-19 condition who have respiratory or cardiac complaints?

15. Should computed tomography of the chest (CT Chest) versus no CT of the chest be used in people with suspected post COVID-19 condition who have respiratory or cardiac complaints (low risk of pulmonary complications)?

16. Should computed tomography of the chest (CT Chest) versus no CT of the chest be used in people with suspected post COVID-19 condition who have respiratory or cardiac complaints (high risk of pulmonary complications)?

17. Should the 10-minute standing test versus no 10-minute standing test be used in adults with suspected post COVID-19 condition who have dizziness?

18. Should questionnaires versus no questionnaires be used in people with suspected post COVID-19 condition who have Post Exertional Malaise (PEM)/Post Exertional Symptom Exacerbation (PESE)?

You can find more information about the project on our website: canpcc.ca or through our newsletter here: https://forms.office.com/Pages/Respon...

Stay connected with us on all our social media platforms:
https://x.com/CochraneCanada
  / cochranecanada  
  / cochrane-canada